Home › Targets › 5-HT7
5-HT7 (3 companies · 11 programs)
Companies with an active program directed at 5-HT7.
- brilaroxazine — Schizophrenia Phase 3
- brilaroxazine — Bipolar Disorder
- brilaroxazine — Major Depressive Disorder
- brilaroxazine — Attention-Deficit/Hyperactivity Disorder
- brilaroxazine — Behavioral and Psychotic Symptoms of Dementia
- brilaroxazine — Parkinson's Disease Psychosis
- brilaroxazine — Pulmonary Arterial Hypertension Preclinical
- brilaroxazine — Idiopathic Pulmonary Fibrosis Preclinical
- brilaroxazine — Psoriasis Preclinical
- dimethyltryptamine — Treatment-Resistant Depression Phase 2
- LB-102 — Schizophrenia Phase 3
